Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Amsterdam  >  Royal DSM    DSM   NL0000009827

ROYAL DSM (DSM)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Royal DSM : DSM hosts successful 2017 Innovation Partnering Conference with eight promising food & biotech start-ups in Delft

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/06/2017 | 10:10am CEST

Speaking at the opening of the conference, Patrick Niels, President of DSM Food Specialties, emphasized the importance of venturing and open innovation in the modern business world: 'At DSM Food Specialties, we aim to enable better food for everyone, helping to make people's diets healthier, tastier, and more sustainable. Encouraging open innovation like this is an important part of our approach; there are so many great ideas and courageous start-ups out there, and this is one way for us to tap into them, hopefully to the benefit of our customers, our business - and of course for the entrepreneurs themselves.'

Eight finalists

An expert panel from DSM and Nutrition Capital Network evaluated a long-list of entrepreneurs and innovators who applied to attend Connecting Bright Innovations 2017, ultimately inviting eight companies to pitch in Delft.

The finalists were: 3f Bio (UK), Alderys (France), Biosyntia (Denmark), Chinova Bioworks (Canada), Kiverdi (US), Pectcof (Netherlands), Swiss DeCode (Switzerland) and Zymtronix (US).

High standard

Krijn Rietveld, Senior Vice President Partnering for Innovation at DSM, heads the Connecting Bright Innovations 2017 panel: 'We were impressed by the high standard of the pitches we heard during the conference, so congratulations to all who took part. It's inspiring to see such passion, drive and energy. The technologies and business cases on show were very interesting, and I am sure that there are a number with whom we will be able to take our relationship further, to see how DSM can help scale up their promising platforms to realize their full commercial potential.'

Delft, world-leading location for biotech

Connecting Bright Innovations 2017 was held at the Rosalind Franklin Biotechnology Center on the DSM site in Delft. The center's location at the heart of the Biotech Campus Delft allows DSM to rapidly develop and scale up biotechnology solutions for promising new ingredients for customer validation and commercial roll-out. The Biotech Campus Delft, an initiative of DSM Delft, Delft University of Technology, the City of Delft and the Province of South Holland, builds on the location's existing competences and internationally recognized position as a world leader in biotechnology development. It brings together fundamental science and R&D, applications expertise, piloting and scale-up facilities as well commercial and market insights and relationships on one location, being also the global headquarters of DSM Food Specialties.

Koninklijke DSM NV published this content on 06 October 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 06 October 2017 08:09:04 UTC.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ROYAL DSM
10/17 ROYAL DSM : DSM expands water management range with new ForTii® Ace high-perform..
10/16 DSM INSIGHT SERIES : Sugar concern on the rise with 47% of consumers more concer..
10/13 ROYAL DSM : World Resources Institute honors Feike Sijbesma for leadership
10/12 ROYAL DSM : DSM announces partnership with Cerapedics to develop and manufacture..
10/10 ROYAL DSM : DSM announces Somos® distribution agreement with RP America
10/10 AMYRIS : Enters into Product Development and Production Agreement with Royal DSM..
10/09 AERIE PHARMACEUTICALS : Announces Drug Delivery Asset Acquisition to Further Adv..
10/06 ROYAL DSM : DSM hosts successful 2017 Innovation Partnering Conference with eigh..
10/04 PPG INDUSTRIES : DSM - New Sigma Air Pure paint made with Decovery bio based res..
10/02 ROYAL DSM : DSM announces collaboration between Somos® and 3D Hubs for 3D printe..
More news
News from SeekingAlpha
10/17 Why I Bought Corbion In Order To Continue Investing In The Technology Of Terr..
08/06 Royal DSM's (RDSMY) CEO Feike Sijbesma on Q2 2017 Results - Earnings Call Tra..
08/01 Royal DSM NV ADR reports Q2 results
05/07 Royal DSM (RDSMY) Q1 2017 Results - Earnings Call Transcript
05/02 Royal DSM NV ADR reports Q1 results
Financials (€)
Sales 2017 8 447 M
EBIT 2017 904 M
Net income 2017 690 M
Debt 2017 1 328 M
Yield 2017 2,56%
P/E ratio 2017 16,32
P/E ratio 2018 17,05
EV / Sales 2017 1,70x
EV / Sales 2018 1,64x
Capitalization 13 063 M
Chart ROYAL DSM
Duration : Period :
Royal DSM Technical Analysis Chart | DSM | NL0000009827 | 4-Traders
Technical analysis trends ROYAL DSM
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 72,2 €
Spread / Average Target 0,29%
EPS Revisions
Managers
NameTitle
Feike Sijbesma CEO & Chairman-Management Board
Robert John Routs Chairman-Supervisory Board
Géraldine Matchett Chief Financial Officer & Member-Management Board
Robert M. van Leen Head-Innovation, Research & Development
Tom de Swaan Vice Chairman-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
ROYAL DSM26.81%15 375
BASF0.67%96 246
GROUPE BRUXELLES LAMBERT13.92%17 243
EVONIK INDUSTRIES7.91%16 836
MITSUBISHI CHEMICAL HOLDINGS CORP.49.33%15 169
FMC CORP65.70%12 744